Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ttp399
1. Ttp399
2. Cadisegliatin [usan]
3. 98s8sh8unf
4. Nn9108
5. Nnc 80-3315
6. Ttp-00223399
7. 859525-02-3
8. Nnc 0080-0000-3315
9. Unii-98s8sh8unf
10. Schembl999940
11. Schembl999941
12. Schembl2648148
13. Schembl21516045
14. Ttp-399
15. Glxc-25387
16. Who 12146
17. Zinc115001082
18. Zinc149397570
19. Nn-9108
20. Hy-147254
21. Cs-0542308
22. {2-[3-cyclohexyl-3-(cis-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic Acid
23. {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic Acid
24. 2-((2-(3-cyclohexyl-3-((1r,4r)-4-propoxycyclohexyl)ureido)thiazol-5-yl)thio)acetic Acid
25. Acetic Acid, 2-((2-(((cyclohexyl(trans-4-propoxycyclohexyl)amino)carbonyl)amino)-5-thiazolyl)thio)-
| Molecular Weight | 455.6 g/mol |
|---|---|
| Molecular Formula | C21H33N3O4S2 |
| XLogP3 | 4.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 9 |
| Exact Mass | 455.19124889 g/mol |
| Monoisotopic Mass | 455.19124889 g/mol |
| Topological Polar Surface Area | 145 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 554 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Cadisegliatin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cadisegliatin, including repackagers and relabelers. The FDA regulates Cadisegliatin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cadisegliatin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cadisegliatin supplier is an individual or a company that provides Cadisegliatin active pharmaceutical ingredient (API) or Cadisegliatin finished formulations upon request. The Cadisegliatin suppliers may include Cadisegliatin API manufacturers, exporters, distributors and traders.
Cadisegliatin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cadisegliatin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cadisegliatin GMP manufacturer or Cadisegliatin GMP API supplier for your needs.
A Cadisegliatin CoA (Certificate of Analysis) is a formal document that attests to Cadisegliatin's compliance with Cadisegliatin specifications and serves as a tool for batch-level quality control.
Cadisegliatin CoA mostly includes findings from lab analyses of a specific batch. For each Cadisegliatin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cadisegliatin may be tested according to a variety of international standards, such as European Pharmacopoeia (Cadisegliatin EP), Cadisegliatin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cadisegliatin USP).
LOOKING FOR A SUPPLIER?
